Enzyme Indicators Proven As Viable Alternative For HPV Decontamination Validation

Enzyme Indicators (EI’s) have been proven as a revolutionary viable alternative to biological indicators (BI’s) for Hydrogen Peroxide decontamination validation. A white paper published today by the Parenteral Drug Association (PDA) Journal of Pharmaceutical Science & Technology, and written by Public Health England (PHE), states that Enzyme Indicators are a “potentially valuable tool for rapid…

Howorth Air Technology Trials Enzyme Indicators Successfully

We like to encourage all of our customers to trial Enzyme Indicators for decontamination validation alongside Biological Indicators when first considering this revolutionary technology. It’s vital that pharmaceutical companies have trust in the product and a clear indication of the benefits EI’s can bring versus the traditional biological indicators. Read on to see how Howorth…

Global Exclusive License Signed

After nearly 18 months of development and negotiation, we are pleased to announce that Protak Scientific have been selected to be the global exclusive partner for Public Health England (PHE) (which is an executive agency of the Department of Health in the United Kingdom), for the commercialisation and development of thermostable Adenylate Kinase for verification…

Global Exclusive License Signed

After nearly 18 months of development and negotiation, we are pleased to announce that Protak Scientific have been selected to be the global exclusive partner for Public Health England (PHE) (which is an executive agency of the Department of Health in the United Kingdom), for the commercialisation and development of thermostable Adenylate Kinase for verification…

Global Exclusive License Signed

After nearly 18 months of development and negotiation, we are pleased to announce that Protak Scientific have been selected to be the global exclusive partner for Public Health England (PHE) (which is an executive agency of the Department of Health in the United Kingdom), for the commercialisation and development of thermostable Adenylate Kinase for verification…

Global Exclusive License Signed

After nearly 18 months of development and negotiation, we are pleased to announce that Protak Scientific have been selected to be the global exclusive partner for Public Health England (PHE) (which is an executive agency of the Department of Health in the United Kingdom), for the commercialisation and development of thermostable Adenylate Kinase for verification…